Aqua Bio Technology ASA: Share capital increase registered

23 Mar 2026 12:02 CET

Reference is made to the stock exchange announcement by Aqua Bio Technology
ASA ("ABTEC" or the "Company") on 12 February 2026 regarding the agreement
with the sellers of Jetcarrier AS to convert NOK 50,000,000 of the currently
outstanding seller credit into new shares in the Company at the same
subscription price as in the private placement that was carried out by the
Company 12 February 2026 (the "Conversion"). Reference is further made to the
stock exchange announcement by the Company on 13 March 2026 regarding the
completion of the extraordinary general meeting in the Company. The general
meeting inter alia resolved to increase the Company's share capital by NOK
50,000,000 through the issuance of 10,000,000 new shares in connection with
the Conversion, each with a par value of NOK 5.00.

The share capital increase pertaining to the Conversion has now been
registered with the Norwegian Register of Business Enterprises. The new share
capital of ABTEC is NOK 76,139,675 divided by 15,227,935 shares, each with a
par value of NOK 5.00.

Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA

Phone: +47 9509 2322
Email: kf@aquabiotech.no

About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in
skincare and nonfood. The group has distribution towards B2C and B2B, and
offers freight, customs, and logistics services. The group also develops
sustainable biotechnology for use in skincare products. Aqua Bio Technology is
listed on Euronext Expand Oslo.

This notice is published by Kristian Flaten on the listed date and time.

This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-03-23 12:02 CET.

More information:
Access the news on Oslo Bors NewsWeb site

669078_Aqua Bio Technology ASA- Share capital increase registered.pdf